EXHIBIT 99.01
Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com | ![]() |
Press Release |
Annual Information Update
Basingstoke, UK – 20 May 2008 – Shire plc (the "Company") (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces the Annual Information Update in accordance with the requirements of Prospectus Rule 5.2.1R. This is in relation to information that has been published or made available to the public between 20 June 2007 and 19 May 2008.
This Annual Information Update is also being made available on the Investors section of the Company’s website, www.shire.com.
The information referred to in this Annual Information Update was correct at the time the information was published, but some information may now be out of date. The information appears by way of record and the Company is under no obligation to update it.
1. | Announcements made via a RIS |
The documents listed below were published via a Regulatory Information Service on or around the dates indicated.
Date | Announcement | ||
09-May-08 | Result of EGM | ||
01-May-08 | Total Voting Rights | ||
01-May-08 | Shire welcomes the Court of Appeal's decision | ||
30-Apr-08 | Holding(s) in Company | ||
29-Apr-08 | Publication of Supplementary Prospectus | ||
25-Apr-08 | Good start to the year reaffirms full year 2008 guidance | ||
24-Apr-08 | Dr Michael Rosenblatt appointed Non-Executive Director | ||
24-Apr-08 | Shire enhances its orphan drug pipeline | ||
23-Apr-08 | FDA Approves VYVANSE to Treat ADHD in Adults | ||
16-Apr-08 | New Shire Holding Company Proposal | ||
16-Apr-08 | Notice of Results | ||
15-Apr-08 | SHIRE TO INTRODUCE A NEW UK LISTED HOLDING COMPANY | ||
04-Apr-08 | Annual Report and Accounts | ||
02-Apr-08 | Director/PDMR Shareholding | ||
01-Apr-08 | Total Voting Rights | ||
31-Mar-08 | Director/PDMR Shareholding |
Registered in England 5492592 Registered Office as above
26-Mar-08 | Shire and TAP Agree to Co-promote LIALDA | ||
26-Mar-08 | Director/PDMR Shareholding | ||
25-Mar-08 | IFRS results for the year ending December 31, 2007 | ||
03-Mar-08 | Renovo announces results of latest JUVISTA P2 studies | ||
03-Mar-08 | Total Voting Rights | ||
26-Feb-08 | Director/PDMR Shareholding | ||
25-Feb-08 | Director/PDMR Shareholding | ||
21-Feb-08 | Notification of major interests in shares | ||
21-Feb-08 | Full year 2007 results | ||
20-Feb-08 | Correction re website | ||
13-Feb-08 | Shire's ELAPRASE Approved in Mexico | ||
12-Feb-08 | Full Year Results Date Notification - 21 February 2008 | ||
12-Feb-08 | Notification of major interests in shares | ||
01-Feb-08 | Total Voting Rights | ||
03-Jan-08 | Total Voting Rights - Correction | ||
02-Jan-08 | Total Voting Rights | ||
21-Dec-07 | Director/PDMR Shareholding | ||
19-Dec-07 | Application for Block Listing | ||
17-Dec-07 | Holdings in Company | ||
14-Dec-07 | Shire In-licensing Agreement Alba Therapeutics | ||
13-Dec-07 | Board Changes | ||
07-Dec-07 | Holding(s) in Company | ||
05-Dec-07 | Holding(s) in Company | ||
03-Dec-07 | Total Voting Rights | ||
29-Nov-07 | Acquisition of Shares | ||
26-Nov-07 | Blocklisting - Interim Review | ||
08-Nov-07 | Shire expands its HGT pipeline through in-licensing | ||
02-Nov-07 | Director/PDMR Shareholding | ||
02-Nov-07 | Director/PDMR Shareholding | ||
01-Nov-07 | Total Voting Rights | ||
01-Nov-07 | Further upgrade to 2007 financial guidance - Q3 Results | ||
31-Oct-07 | David Mott appointed Non Executive Director at Shire | ||
17-Oct-07 | Correction: Notice of Results | ||
17-Oct-07 | Notice of Results | ||
08-Oct-07 | Shire divests non-core product portfolio to Almirall | ||
05-Oct-07 | ELAPRASE Approved in Japan | ||
01-Oct-07 | Total Voting Rights | ||
24-Sep-07 | Shire Appoints Sylvie Gregoire President of HGT | ||
21-Sep-07 | Holding(s) in Company | ||
17-Sep-07 | Availability of 2007 Interim at UKLA Document Viewing | ||
13-Sep-07 | IFRS Information - First half of 2007 | ||
12-Sep-07 | Director/PDMR Shareholding | ||
12-Sep-07 | Director/PDMR Shareholding | ||
03-Sep-07 | Total Voting Rights | ||
15-Aug-07 | Expiry of Hart-Scott-Rodino waiting period for JUVISTA | ||
07-Aug-07 | Director/PDMR Shareholding | ||
03-Aug-07 | Director/PDMR Shareholding | ||
02-Aug-07 | Notification of the Exercise of an Option | ||
02-Aug-07 | Notification of major interests in shares | ||
02-Aug-07 | Total Voting Rights | ||
27-Jul-07 | Application for Share Listing | ||
26-Jul-07 | 2007 guidance upgraded as revenue growth accelerates |
Registered in England 5492592 Registered Office as above
25-Jul-07 | Shire Board Changes | |
19-Jul-07 | Q2 2007 results Timing of meeting changed | |
18-Jul-07 | Q2 2007 results date notification - 26 July 2007 | |
02-Jul-07 | Total Voting Rights | |
02-Jul-07 | Filing of VYVANSE for the Treatment of ADHD in Adults | |
25-Jun-07 | Notification of major interests in shares | |
21-Jun-07 | Shire Receives FDA Approvable Letter for INTUNIV(TM) | |
20-Jun-07 | Result of AGM | |
20-Jun-07 | Holding(s) in Company | |
20-Jun-07 | Shire in-licenses JUVISTA(R) (human TGFB3) from Renovo | |
20-Jun-07 | Annual Information Update |
2. Documents filed at Companies House
All documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated, and can be obtained from Companies House via their website www.companieshouse.gov.uk.
Date | Document | |
22/06/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
26/06/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
02/07/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
06/07/2007 | Resolution – Disapplication of pre-emption rights and authority to allot shares | |
10/07/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
23/07/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
27/07/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
09/08/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
13/08/2007 | Form 88(2)R - Return of an Allotment of Shares | |
14/08/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
23/08/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
31/08/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
05/09/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
28/09/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
05/10/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
19/10/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
02/11/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
13/11/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
16/11/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
06/12/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
13/12/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
19/12/2007 | Form 88(2)R - Return of an Allotment of Shares | |
21/12/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
27/12/2007 | Forms 88(2)R - Return of an Allotment of Shares | |
04/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
14/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
16/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
17/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
21/01/2008 | Form 288a – Appointment of a Director | |
25/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
31/01/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
13/02/2008 | Forms 88(2)R - Return of an Allotment of Shares |
Registered in England 5492592 Registered Office as above
27/02/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
28/02/2008 | Form 88(2)R - Return of an Allotment of Shares | |
06/03/2008 | Form 88(2)R - Return of an Allotment of Shares | |
11/03/2008 | Form 88(2)R - Return of an Allotment of Shares | |
12/03/2008 | Form 88(2)R - Return of an Allotment of Shares | |
12/04/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
14/04/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
23/04/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
24/04/2008 | Resolution – Cancellation of subscriber shares | |
24/04/2008 | Articles of Association | |
24/04/2008 | Form 122 | |
12/05/2008 | Resolutions – Scheme of arrangement; authority to allot shares and adoption of articles of association | |
15/05/2008 | Forms 88(2)R - Return of an Allotment of Shares | |
19/05/2008 | Form 122 | |
19/05/2008 | Resolution – Cancellation of special voting shares |
3. | Documents filed with the Securities and Exchange Commission (“SEC”) |
The Company submitted filings to the SEC in compliance with its obligations under national laws and rules dealing with the regulation of securities, issuers of securities and securities markets by virtue of having American Depository shares admitted to trading on the NASDAQ. Full details of these filings can be found on the SEC’s website at www.sec.gov.
4. Documents sent to Shareholders
The following documents were published and sent to shareholders. They are available on the Company’s website.
Date | Document |
17/09/2007 | Interim Report |
16/04/2008 | Notice of Court Meeting |
16/04/2008 | Notice of Extraordinary General Meeting |
16/04/2008 | Circular – Recommend proposal to establish Shire Limited |
A copy of this Annual Information Update and copies of the documents referred to in it can be obtained from the Deputy Company Secretary at the Company’s registered office.
T May
Company Secretary
For further information please contact:
Investor Relations | Cléa Rosenfeld (Rest of the World) | +44 1256 894 160 |
Eric Rojas (North America) | +1 484 595 8252 |
Registered in England 5492592 Registered Office as above
Notes to editors
SHIRE PLC
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company’s website: www.shire.com.
Registered in England 5492592 Registered Office as above